Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hogg Robert

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Geographic Areas

Procedures

Chemicals & Drugs

Concepts & Ideas

Living Beings

HIV-1

Activities & Behaviors

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Deeks Steven G; Gange Stephen J; Kitahata Mari M; Saag Michael S; Justice Amy C; Hogg Robert S; Eron Joseph J; Brooks John T; Rourke Sean B; Gill M John; Bosch Ronald J; Benson Constance A; Collier Ann C; Martin Jeffrey N; Klein Marina B; Jacobson Lisa P; Rodriguez Benigno; Sterling Timothy R; Kirk Gregory D; Napravnik Sonia; Rachlis Anita R; Calzavara Liviana M; Horberg Michael A; Silverberg Michael J; Gebo Kelly A; Kushel Margot B; Goedert James J; McKaig Rosemary G; Moore Richard D
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
Weiser Sheri D; Fernandes Kimberly A; Brandson Eirikka K; Lima Viviane D; Anema Aranka; Bangsberg David R; Montaner Julio S; Hogg Robert S
The association between food insecurity and mortality among HIV-infected individuals on HAART.
Lanoy Emilie; May Margaret; Mocroft Amanda; Phillip Andrew; Justice Amy; Chêne Geneviève; Furrer Hansjakob; Sterling Timothy; Monforte Antonella D'Arminio; Force Lluís; Gill John; Harris Ross; Hogg Robert S; Rockstroh Jürgen; Saag Mike; Khaykin Pavel; de Wolf Frank; Sterne Jonathan A C; Costagliola Dominique
Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hogg Robert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Deeks Steven G; Gange Stephen J; Kitahata Mari M; Saag Michael S; Justice Amy C; Hogg Robert S; Eron Joseph J; Brooks John T; Rourke Sean B; Gill M John; Bosch Ronald J; Benson Constance A; Collier Ann C; Martin Jeffrey N; Klein Marina B; Jacobson Lisa P; Rodriguez Benigno; Sterling Timothy R; Kirk Gregory D; Napravnik Sonia; Rachlis Anita R; Calzavara Liviana M; Horberg Michael A; Silverberg Michael J; Gebo Kelly A; Kushel Margot B; Goedert James J; McKaig Rosemary G; Moore Richard D
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(10):1582-90.
2009: Weiser Sheri D; Fernandes Kimberly A; Brandson Eirikka K; Lima Viviane D; Anema Aranka; Bangsberg David R; Montaner Julio S; Hogg Robert S
The association between food insecurity and mortality among HIV-infected individuals on HAART.
Journal of acquired immune deficiency syndromes (1999) 2009;52(3):342-9.
2009: Lanoy Emilie; May Margaret; Mocroft Amanda; Phillip Andrew; Justice Amy; Chêne Geneviève; Furrer Hansjakob; Sterling Timothy; Monforte Antonella D'Arminio; Force Lluís; Gill John; Harris Ross; Hogg Robert S; Rockstroh Jürgen; Saag Mike; Khaykin Pavel; de Wolf Frank; Sterne Jonathan A C; Costagliola Dominique
Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
AIDS (London, England) 2009;23(16):2199-208.
2009: Kaida Angela; Bangsberg David R; Gray Glenda; Hogg Robert S; King Rachel; Miller Cari L
Editorial: Introduction to the Supplement on HIV, HAART, and Fertility in sub-Saharan Africa.
AIDS and behavior 2009;13 Suppl 1():1-4.
2009: Kaida Angela; Lima Viviane Dias; Andia Irene; Kabakyenga Jerome; Mbabazi Pamela; Emenyonu Nneka; Patterson Thomas L; Hogg Robert S; Bangsberg David R
The WHOMEN's scale (Women's HAART Optimism Monitoring and EvaluatioN Scale v.1) and the association with fertility intentions and sexual behaviours among HIV-positive women in Uganda.
AIDS and behavior 2009;13 Suppl 1():72-81.
2009: Forrest Jamie I; Kaida Angela; Dietrich Janan; Miller Cari L; Hogg Robert S; Gray Glenda
Perceptions of HIV and fertility among adolescents in Soweto, South Africa: stigma and social barriers continue to hinder progress.
AIDS and behavior 2009;13 Suppl 1():55-61.
2009: Maier Marissa; Andia Irene; Emenyonu Nneka; Guzman David; Kaida Angela; Pepper Larry; Hogg Robert; Bangsberg David R
Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda.
AIDS and behavior 2009;13 Suppl 1():28-37.
2009: Iñiguez-Stevens Esmeralda; Brouwer Kimberly C; Hogg Robert S; Patterson Thomas L; Lozada Remedios; Magis-Rodríguez Carlos; Elder John P; Viani Rolando M; Strathdee Steffanie A
[Estimating the 2006 prevalence of HIV by gender and risk groups in Tijuana, Mexico]
Gaceta médica de México 2009;145(3):189-95.
2009: Druyts E F; Rachlis B S; Lima V D; Harvard S S; Zhang W; Brandson E K; Strathdee S A; Montaner J S G; Hogg R S
Mortality is influenced by locality in a major HIV/AIDS epidemic.
HIV medicine 2009;10(5):274-81.
2009: Kitahata Mari M; Gange Stephen J; Abraham Alison G; Merriman Barry; Saag Michael S; Justice Amy C; Hogg Robert S; Deeks Steven G; Eron Joseph J; Brooks John T; Rourke Sean B; Gill M John; Bosch Ronald J; Martin Jeffrey N; Klein Marina B; Jacobson Lisa P; Rodriguez Benigno; Sterling Timothy R; Kirk Gregory D; Napravnik Sonia; Rachlis Anita R; Calzavara Liviana M; Horberg Michael A; Silverberg Michael J; Gebo Kelly A; Goedert James J; Benson Constance A; Collier Ann C; Van Rompaey Stephen E; Crane Heidi M; McKaig Rosemary G; Lau Bryan; Freeman Aimee M; Moore Richard D;
Effect of early versus deferred antiretroviral therapy for HIV on survival.
The New England journal of medicine 2009;360(18):1815-26.
2009: Mocroft Amanda; Sterne Jonathan A C; Egger Matthias; May Margaret; Grabar Sophie; Furrer Hansjakob; Sabin Caroline; Fatkenheuer Gerd; Justice Amy; Reiss Peter; d'Arminio Monforte Antonella; Gill John; Hogg Robert; Bonnet Fabrice; Kitahata Mari; Staszewski Schlomo; Casabona Jordi; Harris Ross; Saag Michael
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(8):1138-51.
2009: Lima Viviane D; Harrigan Richard; Bangsberg David R; Hogg Robert S; Gross Robert; Yip Benita; Montaner Julio S G
The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.
Journal of acquired immune deficiency syndromes (1999) 2009;50(5):529-36.
2009: Lima Viviane D; Fink Valeria; Yip Benita; Hogg Robert S; Harrigan P Richard; Montaner Julio S G
Association between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals.
American journal of public health 2009;99 Suppl 1():S193-6.
2009: Lima Viviane; Fernandes Kimberly; Rachlis Beth; Druyts Eric; Montaner Julio; Hogg Robert
Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients.
Social science & medicine (1982) 2009;68(6):1044-9.
2009: Druyts E F; Yip B; Lima V D; Burke T A; Lesovski D; Fernandes K A; McInnes C W; Rustad C A; Montaner J S G; Hogg R S
Health care services utilization stratified by virological and immunological markers of HIV: evidence from a universal health care setting.
HIV medicine 2009;10(2):88-93.
2009: Andia Irene; Kaida Angela; Maier Marissa; Guzman David; Emenyonu Nneka; Pepper Larry; Bangsberg David R; Hogg Robert S
Highly active antiretroviral therapy and increased use of contraceptives among HIV-positive women during expanding access to antiretroviral therapy in Mbarara, Uganda.
American journal of public health 2009;99(2):340-7.
2009: Weiser Sheri D; Frongillo Edward A; Ragland Kathleen; Hogg Robert S; Riley Elise D; Bangsberg David R
Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco.
Journal of general internal medicine 2009;24(1):14-20.
2009: Wood Evan; Kerr Thomas; Marshall Brandon D L; Li Kathy; Zhang Ruth; Hogg Robert S; Harrigan P Richard; Montaner Julio S G
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.
BMJ (Clinical research ed.) 2009;338():b1649.
2009: McInnes Colin W; Druyts Eric; Harvard Stephanie S; Gilbert Mark; Tyndall Mark W; Lima Viviane D; Wood Evan; Montaner Julio Sg; Hogg Robert S
HIV/AIDS in Vancouver, British Columbia: a growing epidemic.
Harm reduction journal 2009;6():5.
2008: Mugavero Michael J; May Margaret; Harris Ross; Saag Michael S; Costagliola Dominique; Egger Matthias; Phillips Andrew; Günthard Huldrych F; Dabis Francois; Hogg Robert; de Wolf Frank; Fatkenheuer Gerd; Gill M John; Justice Amy; D'Arminio Monforte Antonella; Lampe Fiona; Miró Jose M; Staszewski Schlomo; Sterne Jonathan A C
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?
AIDS (London, England) 2008;22(18):2481-92.
2008: Lima Viviane D; Harrigan Richard; Murray Melanie; Moore David M; Wood Evan; Hogg Robert S; Montaner Julio Sg
Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
AIDS (London, England) 2008;22(17):2371-80.
2008: Tam Lily W Y; Chui Celia K S; Brumme Chanson J; Bangsberg David R; Montaner Julio S G; Hogg Robert S; Harrigan P Richard
The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes.
Journal of acquired immune deficiency syndromes (1999) 2008;49(3):266-71.
2008: Schilder Arn J; Orchard Treena R; Buchner Christopher S; Miller Mary Lou; Fernandes Kim A; Hogg Robert S; Strathdee Steffanie A
'It's like the treasure': beliefs associated with semen among young HIV-positive and HIV-negative gay men.
Culture, health & sexuality 2008;10(7):667-79.
2008: Fielden Sarah J; Rusch Melanie L A; Yip Benita; Wood Evan; Shannon Kate; Levy Adrian R; Montaner Julio S G; Hogg Robert S
Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2008;7(5):238-44.
2008: Rachlis Beth S; Hogg Robert S; Wood Evan; Li Kathy; Kerr Thomas
Factors associated with geographic migration among a cohort of injection drug users.
Health & place 2008;14(3):536-43.
2008: Wood Evan; Hogg Robert S; Lima Viviane Dias; Kerr Thomas; Yip Benita; Marshall Brandon D L; Montaner Julio S G
Highly active antiretroviral therapy and survival in HIV-infected injection drug users.
JAMA : the journal of the American Medical Association 2008;300(5):550-4.
2008: Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg R S; Montaner J S G
Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
HIV medicine 2008;9(7):503-7.
2008: Kerr Thomas; Hogg Robert S; Yip Benita; Tyndall Mark W; Montaner Julio; Wood Evan
Validity of self-reported adherence among injection drug users.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2008;7(4):157-9.
2008: Lima Viviane D; Johnston Karissa; Hogg Robert S; Levy Adrian R; Harrigan P Richard; Anema Aranka; Montaner Julio S G
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.
The Journal of infectious diseases 2008;198(1):59-67.
2008: Lima Viviane D; Gill Vikram S; Yip Benita; Hogg Robert S; Montaner Julio S G; Harrigan P Richard
Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy.
The Journal of infectious diseases 2008;198(1):51-8.
2008: Lampinen Thomas M; Chan Keith; Anema Aranka; Miller Mary Lou; Schilder Arn J; Schechter Martin T; Hogg Robert Stephen; Strathdee Steffanie A
Incidence of and risk factors for sexual orientation-related physical assault among young men who have sex with men.
American journal of public health 2008;98(6):1028-35.
2008: Joy Ruth; Druyts Eric F; Brandson Eirikka K; Lima Viviane D; Rustad Clare A; Zhang Wendy; Wood Evan; Montaner Julio S G; Hogg Robert S
Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting.
Journal of acquired immune deficiency syndromes (1999) 2008;47(4):500-5.
2008: Fielden Sarah J; Rusch Melanie L A; Levy Adrian R; Yip Benita; Wood Evan; Harrigan Richard P; Goldstone Irene; Guillemi Silvia; Montaner Julio S; Hogg Robert S
Predicting hospitalization among HIV-infected antiretroviral naïve patients starting HAART: determining clinical markers and exploring social pathways.
AIDS care 2008;20(3):297-303.
2008: Phillips Elizabeth; Hayden Anna; Gutiérrez Sonia; Jahnke Natalie; Yip Benita; Lima Viviane D; Hogg Robert S; Harrigan P Richard; Montaner Julio S G
Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.
AIDS (London, England) 2008;22(4):548-9.
2008: Low Andrew J; Marchant David; Brumme Chanson J; Brumme Zabrina L; Dong Winnie; Sing Tobias; Hogg Robert S; Montaner Julio S G; Gill Vikram; Cheung Peter K; Harrigan P Richard
CD4-dependent characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individuals.
AIDS research and human retroviruses 2008;24(2):219-28.
2008: Kaida A; Gray G; Bastos F I; Andia I; Maier M; McIntyre J; Grinsztejn B; Strathdee S A; Bangsberg D R; Hogg R
The relationship between HAART use and sexual activity among HIV-positive women of reproductive age in Brazil, South Africa, and Uganda.
AIDS care 2008;20(1):21-5.
2008: Zala Carlos; Rustad Clare A; Chan Keith; Khan Nabeela I; Beltran Marcelo; Warley Eduardo; Ceriotto Mariana; Druyts Eric F; Hogg Robert S; Montaner Julio; Cahn Pedro;
Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in Argentina.
Journal of the International AIDS Society 2008;10(4):78.
2008: Harris Ross J; Sterne Jonathan A C; Abgrall Sophie; Dabis François; Reiss Peter; Saag Michael; Phillips Andrew N; Chêne Geneviève; Gill John M; Justice Amy C; Rockstroh Jürgen; Sabin Caroline A; Mocroft Amanda; Bucher Heiner C; Hogg Robert S; Monforte Antonella D'Arminio; May Margaret; Egger Matthias;
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.
Antiviral therapy 2008;13(8):959-67.
2008: Zala Carlos; Rustad Clare A; Chan Keith; Khan Nabeela I; Beltran Marcelo; Warley Eduardo; Ceriotto Mariana; Druyts Eric F; Hogg Robert S; Montaner Julio; Cahn Pedro;
Determinants of treatment access in a population-based cohort of HIV-positive men and women living in Argentina.
Medscape journal of medicine 2008;10(4):78.
2008: Hogg Robert S; Druyts Eric F; Burris Scott; Drucker Ernest; Strathdee Steffanie A
Years of life lost to prison: racial and gender gradients in the United States of America.
Harm reduction journal 2008;5():4.
2007: Dhalla S; Woods R; Strathdee S A; Patrick D M; Hogg R S
HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries.
AIDS care 2007;19(9):1118-27.
2007: Rachlis Beth; Brouwer Kimberly C; Mills Edward J; Hayes Michael; Kerr Thomas; Hogg Robert S
Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridge.
Drug and alcohol dependence 2007;90(2-3):107-19.
2007: Wood Evan; Kerr Thomas; Tyndall Mark W; Zhang Ruth; Hogg Robert S; Strathdee Steffanie A; Montaner Julio S G
Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users.
Addiction (Abingdon, England) 2007;102(9):1503-5.
2007: Normén L; Yip B; Montaner J; Harris M; Frohlich J; Bondy G; Hogg R S
Use of metabolic drugs and fish oil in HIV-positive patients with metabolic complications and associations with dyslipidaemia and treatment targets.
HIV medicine 2007;8(6):346-56.
2007: Phillips Elizabeth; Gutiérrez Sonia; Jahnke Natalie; Yip Benita; Lima Viviane D; Hogg Robert S; Harrigan P Richard; Montaner Julio S G
Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
AIDS (London, England) 2007;21(12):1561-8.
2007: Brumme Zabrina L; Brumme Chanson J; Heckerman David; Korber Bette T; Daniels Marcus; Carlson Jonathan; Kadie Carl; Bhattacharya Tanmoy; Chui Celia; Szinger James; Mo Theresa; Hogg Robert S; Montaner Julio S G; Frahm Nicole; Brander Christian; Walker Bruce D; Harrigan P Richard
Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
PLoS pathogens 2007;3(7):e94.
2007: Tam L W Y; Hogg R S; Yip B; Montaner J S G; Harrigan P R; Brumme C J
Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naïve individuals in a Western setting.
HIV medicine 2007;8(5):267-70.
2007: Brumme Zabrina L; Brumme Chanson J; Chui Celia; Mo Theresa; Wynhoven Brian; Woods Conan K; Henrick Bethany M; Hogg Robert S; Montaner Julio S G; Harrigan P Richard
Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy.
The Journal of infectious diseases 2007;195(11):1694-704.
2007: Ezzat H; Filipenko D; Vickars L; Galbraith P; Li C; Murphy K; Montaner J S G; Harris M; Hogg R S; Vercauteren S; Leger C S; Zypchen L; Leitch H A
Improved survival in HIV-associated diffuse large B-cell lymphoma with the addition of rituximab to chemotherapy in patients receiving highly active antiretroviral therapy.
HIV clinical trials 2007;8(3):132-44.
2007: May Margaret; Sterne Jonathan A C; Sabin Caroline; Costagliola Dominique; Justice Amy C; Thiébaut Rodolphe; Gill John; Phillips Andrew; Reiss Peter; Hogg Robert; Ledergerber Bruno; D'Arminio Monforte Antonella; Schmeisser Norbert; Staszewski Shlomo; Egger Matthias;
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies.
AIDS (London, England) 2007;21(9):1185-97.
2007: Lima Viviane D; Geller Josie; Bangsberg David R; Patterson Thomas L; Daniel Mark; Kerr Thomas; Montaner Julio S G; Hogg Robert S
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART.
AIDS (London, England) 2007;21(9):1175-83.
2007: Montaner Julio S G; Hogg Robert S
Hungering for HAART.
Annals of internal medicine 2007;146(8):609-10.
2007: Gange Stephen J; Kitahata Mari M; Saag Michael S; Bangsberg David R; Bosch Ronald J; Brooks John T; Calzavara Liviana; Deeks Steven G; Eron Joseph J; Gebo Kelly A; Gill M John; Haas David W; Hogg Robert S; Horberg Michael A; Jacobson Lisa P; Justice Amy C; Kirk Gregory D; Klein Marina B; Martin Jeffrey N; McKaig Rosemary G; Rodriguez Benigno; Rourke Sean B; Sterling Timothy R; Freeman Aimee M; Moore Richard D
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).
International journal of epidemiology 2007;36(2):294-301.
2007: Lima Viviane D; Hogg Robert S; Harrigan P Richard; Moore David; Yip Benita; Wood Evan; Montaner Julio S G
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.
AIDS (London, England) 2007;21(6):685-92.
2007: Wood E; Hogg R S; Yip B; Moore D; Harrigan P R; Montaner J S G
Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme.
HIV medicine 2007;8(2):80-5.
2007: Lima Viviane D; Hogg Robert S; Montaner Julio S G
Presenting plasma HIV RNA level and rate of CD4 T-cell decline.
JAMA : the journal of the American Medical Association 2007;297(8):805-6; author reply 806-7.
2007: George C; Alary M; Hogg R S; Otis J; Remis R S; Mâsse B; Turmel B; Leclerc R; Lavoie R; Vincelette J; Parent R; Chan K; Martindale S; Miller M L; Craib K J P; Schechter M T
HIV and ethnicity in Canada: is the HIV risk-taking behaviour of young foreign-born MSM similar to Canadian born MSM?
AIDS care 2007;19(1):9-16.
2007: Hacker Mariana A; Kaida Angela; Hogg Robert S; Bastos Francisco I
The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006.
Cadernos de saúde pública / Ministério da Saúde, Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública 2007;23 Suppl 3():S345-59.
2007: Lampinen Thomas M; Mattheis Kelly; Chan Keith; Hogg Robert S
Nitrite inhalant use among young gay and bisexual men in Vancouver during a period of increasing HIV incidence.
BMC public health 2007;7():35.
2007: Moore David M; Awor Anna; Downing Robert S; Were Willy; Solberg Peter; Tu David; Chan Keith; Hogg Robert S; Mermin Jonathan
Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index.
AIDS research and therapy 2007;4():1.
2007: Wood Evan; Hogg Robert S; Kerr Thomas; Bonner Simon; Strathdee Steffanie A; Palepu Anita; Montaner Julio S G
Rates of inappropriate antiretroviral prescription among injection drug users.
Harm reduction journal 2007;4():2.
2006: Moore David M; Mermin Jonathan; Awor Anna; Yip Benita; Hogg Robert S; Montaner Julio S G
Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings.
Journal of acquired immune deficiency syndromes (1999) 2006;43(4):436-9.
2006: Lampinen Thomas M; Bonner Simon J; Rusch Melanie; Hogg Robert S
High prevalence of smoking among urban-dwelling Canadian men who have sex with men.
Journal of urban health : bulletin of the New York Academy of Medicine 2006;83(6):1143-50.
2006: Kaida Angela; Andia Irene; Maier Marissa; Strathdee Steffanie A; Bangsberg David R; Spiegel Jerry; Bastos Francisco I; Gray Glenda; Hogg Robert
The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa.
Current HIV/AIDS reports 2006;3(4):187-94.
2006: Dhalla Shayesta; Chan Keith J; Montaner Julio S G; Hogg Robert S
Complementary and alternative medicine use in British Columbia--a survey of HIV positive people on antiretroviral therapy.
Complementary therapies in clinical practice 2006;12(4):242-8.
2006: Miller C L; Spittal P M; Wood E; Chan K; Schechter M T; Montaner J S G; Hogg R S
Inadequacies in antiretroviral therapy use among Aboriginal and other Canadian populations.
AIDS care 2006;18(8):968-76.
2006: Gross Robert; Yip Benita; Lo Re Vincent; Wood Evan; Alexander Christopher S; Harrigan P Richard; Bangsberg David R; Montaner Julio S G; Hogg Robert S
A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression.
The Journal of infectious diseases 2006;194(8):1108-14.
2006: Braitstein P; Li K; Kerr T; Montaner J S G; Hogg R S; Wood E
Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
AIDS care 2006;18(7):690-3.
2006: Braitstein Paula; Asselin Jérôme J; Schilder Arn; Miller Mary-Lou; Laliberté Nancy; Schechter Martin T; Hogg Robert S
Sexual violence among two populations of men at high risk of HIV infection.
AIDS care 2006;18(7):681-9.
2006: Hogg Robert S; Bangsberg David R; Lima Viviane D; Alexander Chris; Bonner Simon; Yip Benita; Wood Evan; Dong Winnie W Y; Montaner Julio S G; Harrigan P Richard
Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.
PLoS medicine 2006;3(9):e356.
2006: Wood Evan; Kerr Thomas; Hogg Robert S; Palepu Anita; Zhang Ruth; Strathdee Steffanie A; Montaner Julio S G
Impact of HIV testing on uptake of HIV therapy among antiretroviral naive HIV-infected injection drug users.
Drug and alcohol review 2006;25(5):451-4.
2006: Moore D M; Hogg R S; Yip B; Craib K; Wood E; Montaner J S G
CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/microL.
HIV medicine 2006;7(6):383-8.
2006: Palepu Anita; Tyndall Mark W; Joy Ruth; Kerr Thomas; Wood Evan; Press Natasha; Hogg Robert S; Montaner Julio S G
Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Drug and alcohol dependence 2006;84(2):188-94.
2006: Montaner Julio S G; Hogg Robert; Wood Evan; Kerr Thomas; Tyndall Mark; Levy Adrian R; Harrigan P Richard
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.
Lancet 2006;368(9534):531-6.
2006: May Margaret T; Sterne Jonathan A C; Costagliola Dominique; Sabin Caroline A; Phillips Andrew N; Justice Amy C; Dabis François; Gill John; Lundgren Jens; Hogg Robert S; de Wolf Frank; Fätkenheuer Gerd; Staszewski Schlomo; d'Arminio Monforte Antonella; Egger Matthias;
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.
Lancet 2006;368(9534):451-8.
2006: Moore D M; Hogg R S; Yip B; Wood E; Harris M; Montaner J S G
Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy.
HIV medicine 2006;7(5):311-6.
2006: Lampinen Thomas M; Latulippe Luc; van Niekerk Dirk; Schilder Arn J; Miller Mary Lou; Anema Aranka; Hogg Robert S
Illustrated instructions for self-collection of anorectal swab specimens and their adequacy for cytological examination.
Sexually transmitted diseases 2006;33(6):386-8.
2006: Wood Evan; Hogg Robert S; Yip Benita; Moore David; Harrigan P Richard; Montaner Julio S G
Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
AIDS (London, England) 2006;20(8):1117-23.
2006: Wood Evan; Kerr Thomas; Hogg Robert S; Zhang Ruth; Tyndall Mark W; Montaner Julio S G
Validity of self-reported antiretroviral therapy use among injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2006;41(4):530-1.
2006: Wood Evan; Kerr Thomas; Palepu Anita; Zhang Ruth; Strathdee Steffanie A; Tyndall Mark W; Montaner Julio S G; Hogg Robert S
Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users.
The Journal of infection 2006;52(4):233-6.
2006: Brouwer Kimberly C; Strathdee Steffanie A; Magis-Rodríguez Carlos; Bravo-García Enrique; Gayet Cecilia; Patterson Thomas L; Bertozzi Stefano M; Hogg Robert S
Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico.
Journal of urban health : bulletin of the New York Academy of Medicine 2006;83(2):299-307.
2006: Levy Adrian R; James Douglas; Johnston Karissa M; Hogg Robert S; Harrigan P Richard; Harrigan Brian P; Sobolev Boris; Montaner Julio S
The direct costs of HIV/AIDS care.
The Lancet infectious diseases 2006;6(3):171-7.
2006: Corneil Trevor A; Kuyper Laura M; Shoveller Jean; Hogg Robert S; Li Kathy; Spittal Patricia M; Schechter Martin T; Wood Evan
Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users.
Health & place 2006;12(1):79-85.
2006: Lloyd-Smith Elisa; Brodkin Elizabeth; Wood Evan; Kerr Thomas; Tyndall Mark W; Montaner Julio S G; Hogg Robert S
Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia.
AIDS (London, England) 2006;20(3):445-50.
2006: Moore David M; Hogg Robert S; Chan Keith; Tyndall Mark; Yip Benita; Montaner Julio S G
Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response.
AIDS (London, England) 2006;20(3):371-7.
2006: Braitstein Paula; Justice Amy; Bangsberg David R; Yip Benita; Alfonso Victoria; Schechter Martin T; Hogg Robert S; Montaner Julio S G
Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort.
AIDS (London, England) 2006;20(3):323-31.
2006: Spittal P M; Hogg R S; Li K; Craib K J; Recsky M; Johnston C; Montaner J S G; Schechter M T; Wood E
Drastic elevations in mortality among female injection drug users in a Canadian setting.
AIDS care 2006;18(2):101-8.
2006: Braitstein Paula; Zala Carlos; Yip Benita; Brinkhof Martin W G; Moore David; Hogg Robert S; Montaner Julio S G
Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
The Journal of infectious diseases 2006;193(2):259-68.
2006: Lampinen Thomas M; Chan Keith; Anema Aranka; Kornegay Janet; Hogg Robert S; Coutlee Francois
Self-screening for rectal sexually transmitted infections: human papillomavirus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(2):308-9.
2006: Kerr Thomas; Stoltz Jo-Anne; Strathdee Steffanie; Li Kathy; Hogg Robert S; Montaner Julio S; Wood Evan
The impact of sex partners' HIV status on HIV seroconversion in a prospective cohort of injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2006;41(1):119-23.
2006: Kuyper Laura M; Kerr Thomas; Li Kathy; Hogg Robert S; Tyndall Mark W; Montaner Julio S G; Wood Evan
Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs.
Substance use & misuse 2006;41(6-7):883-99.
2006: Lima Viviane D; Kretz Patricia; Palepu Anita; Bonner Simon; Kerr Thomas; Moore David; Daniel Mark; Montaner Julio S G; Hogg Robert S
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART.
AIDS research and therapy 2006;3():14.
2006: Lampinen Thomas M; Miller Mary Lou; Chan Keith; Anema Aranka; van Niekerk Dirk; Schilder Arn J; Taylor Robert; Hogg Robert S
Randomized clinical evaluation of self-screening for anal cancer precursors in men who have sex with men.
CytoJournal 2006;3():4.
2006: Moore David M; Hogg Robert S; Braitstein Paula; Wood Evan; Yip Benito; Montaner Julio S G
Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy.
Antiviral therapy 2006;11(1):125-9.
2006: Côté Hélène C F; Magil Alex B; Harris Marianne; Scarth Brian J; Gadawski Izabelle; Wang Nancy; Yu Eugenia; Yip Benita; Zalunardo Nadia; Werb Ron; Hogg Robert; Harrigan P Richard; Montaner Julio S
Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy.
Antiviral therapy 2006;11(1):79-86.
2005: Lloyd-Smith Elisa; Kerr Thomas; Hogg Robert S; Li Kathy; Montaner Julio S G; Wood Evan
Prevalence and correlates of abscesses among a cohort of injection drug users.
Harm reduction journal 2005;2():24.
2005: Moore David M; Hogg Robert S; Yip Benita; Wood Evan; Tyndall Mark; Braitstein Paula; Montaner Julio S G
Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy.
Journal of acquired immune deficiency syndromes (1999) 2005;40(3):288-93.
2005: Toulson Adrienne R; Harrigan Richard; Heath Katherine; Yip Benita; Brumme Zabrina L; Harris Marianne; Hogg Robert S; Montaner Julio S G
Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.
The Journal of infectious diseases 2005;192(10):1787-93.
2005: Phillips Peter; Bonner Simon; Gataric Nada; Bai Tony; Wilcox Pearce; Hogg Robert; O'Shaughnessy Michael; Montaner Julio
Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(10):1483-97.
2005: Lampinen Thomas M; Ogilvie Gina; Chan Keith; Miller Mary Lou; Cook Darrel; Schechter Martin T; Hogg Robert S
Sustained increase in HIV-1 incidence since 2000 among men who have sex with men in British Columbia, Canada.
Journal of acquired immune deficiency syndromes (1999) 2005;40(2):242-4.
2005: Schilder Arn J; Lampinen Thomas M; Miller Mary Lou; Hogg Robert S
Crystal methamphetamine and ecstasy differ in relation to unsafe sex among young gay men.
Canadian journal of public health. Revue canadienne de santé publique 2005;96(5):340-3.
2005: O'Connell Jacqueline M; Kerr Thomas; Li Kathy; Tyndall Mark W; Hogg Robert S; Montaner Julio S; Wood Evan
Requiring help injecting independently predicts incident HIV infection among injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2005;40(1):83-8.
2005: Lem Marcus; Moore David; Marion Stephen; Bonner Simon; Chan Keith; O'Connell Jacqueline; Montaner Julio S G; Hogg Robert
Back to work: correlates of employment among persons receiving highly active antiretroviral therapy.
AIDS care 2005;17(6):740-6.
2005: Brumme Zabrina L; Goodrich James; Mayer Howard B; Brumme Chanson J; Henrick Bethany M; Wynhoven Brian; Asselin Jerome J; Cheung Peter K; Hogg Robert S; Montaner Julio S G; Harrigan P Richard
Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals.
The Journal of infectious diseases 2005;192(3):466-74.
2005: Kuyper Laura M; Collins Courtney Lc; Kerr Thomas; Hogg Robert S; Li Kathy; Tyndall Mark W; Montaner Julio Sg; Wood Evan
The prevalence and incidence of sexually transmitted infections in a prospective cohort of injection drug users in Vancouver, British Columbia.
The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada 2005;16(4):225-9.
2005: Shannon Kate; Kerr Thomas; Lai Calvin; Ishida Tomiye; Wood Evan; Montaner Julio S G; Hogg Robert S; Tyndall Mark W
Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2005;4(3):66-72.
2005: Kerr T; Marshall A; Walsh J; Palepu A; Tyndall M; Montaner J; Hogg R; Wood E
Determinants of HAART discontinuation among injection drug users.
AIDS care 2005;17(5):539-49.
2005: Braitstein Paula; Yip Benita; Montessori Valentina; Moore David; Montaner Julio S G; Hogg Robert S
Effect of serostatus for hepatitis C virus on mortality among antiretrovirally naive HIV-positive patients.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;173(2):160-4.
2005: Wood Evan; Hogg Robert S; Yip Benita; Dong Winnie W Y; Wynhoven Brian; Mo Theresa; Brumme Chanson J; Montaner Julio S G; Harrigan P Richard
Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use.
AIDS (London, England) 2005;19(11):1189-95.
2005: Wood Evan; Hogg Robert S; Harrigan P Richard; Montaner Julio S G
When to initiate antiretroviral therapy in HIV-1-infected adults: a review for clinicians and patients.
The Lancet infectious diseases 2005;5(7):407-14.
2005: Moore David; Hogg Robert; Spiegel Jerry
Global IDEA.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;172(12):1537-8; author reply 1538-9.
2005: Braitstein P; Montessori V; Chan K; Montaner J S G; Schechter M T; O'Shaughnessy M V; Hogg R S
Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.
AIDS care 2005;17(4):505-15.
2005: Wood Evan; Hogg Robert S; Kerr Thomas; Palepu Anita; Zhang Ruth; Montaner Julio S G
Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users.
AIDS (London, England) 2005;19(8):837-9.
2005: Normén Lena; Chan Keith; Braitstein Paula; Anema Aranka; Bondy Greg; Montaner Julio S G; Hogg Robert S
Food insecurity and hunger are prevalent among HIV-positive individuals in British Columbia, Canada.
The Journal of nutrition 2005;135(4):820-5.
2005: McGuire A L; Barer J M; Montaner J S G; Hogg R S
There and back again: the impact of adult HIV prevalence on national life expectancies.
HIV medicine 2005;6(2):57-8.
2005: Wood Evan; Hogg Robert S; Yip Benita; Harrigan P Richard; Montaner Julio S G
Why are baseline HIV RNA levels 100,000 copies/mL or greater associated with mortality after the initiation of antiretroviral therapy?
Journal of acquired immune deficiency syndromes (1999) 2005;38(3):289-95.
2005: Kuyper Laura M; Lampinen Thomas M; Chan Keith; Miller Mary Lou; Schilder Arn; Hogg Robert S
Similar sexual behaviors with casual partners among gay men with and without a regular partner.
Sexually transmitted diseases 2005;32(3):203-5.
2005: Montaner Julio; Harris Marianne; Hogg Robert
Structured treatment interruptions: a risky business.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(4):601-3.
2005: Lampinen Thomas M; Chan Keith; Remis Robert S; Merid Maraki Fikre; Rusch Melanie; Vincelette Jean; Logue Ken; Popovic Vladimir; Alary Michel; Schechter Martin T; Hogg Robert S
Sexual risk behaviour of Canadian participants in the first efficacy trial of a preventive HIV-1 vaccine.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;172(4):479-83.
2005: Harrigan P Richard; Hogg Robert S; Dong Winnie W Y; Yip Benita; Wynhoven Brian; Woodward Justin; Brumme Chanson J; Brumme Zabrina L; Mo Theresa; Alexander Chris S; Montaner Julio S G
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.
The Journal of infectious diseases 2005;191(3):339-47.
2005: Wood Evan; Li Kathy; Miller Cari L; Hogg Robert S; Montaner Julio S G; Schechter Martin T; Kerr Thomas
Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.
International journal of epidemiology 2005;34(1):152-8.
2005: Hogg Robert S; Strathdee Steffanie; Kerr Thomas; Wood Evan; Remis Robert
HIV prevalence among aboriginal British Columbians.
Harm reduction journal 2005;2():26.
2005: Brumme Zabrina L; Henrick Bethany M; Brumme Chanson J; Hogg Robert S; Montaner Julio S G; Harrigan P Richard
Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen.
Antiviral therapy 2005;10(7):849-53.
2005: Wood Evan; Li Kathy; Palepu Anita; Marsh David C; Schechter Martin T; Hogg Robert S; Montaner Julio S G; Kerr Thomas
Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users.
Substance use & misuse 2005;40(8):1153-67.
2005: Levy Adrian R; McCandless Lawrence; Harrigan P Richard; Hogg Robert S; Bondy Greg; Iloeje Uchenna H; Mukherjee Jayanti; Montaner Julio S
Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS.
Lipids in health and disease 2005;4():4.
2004: Wood Evan; Hogg Robert S; Yip Benita; Harrigan P Richard; Montaner Julio S G
Earlier initiation of highly active antiretroviral therapy does not protect against the deleterious effects of non-adherence.
AIDS (London, England) 2004;18(18):2432-4.
2004: Kuyper Laura M; Wood Evan; Montaner Julio S G; Yip Benita; O'connell Jacqueline M; Hogg Robert S
Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-Infected patients in a population-based cohort.
Journal of acquired immune deficiency syndromes (1999) 2004;37(4):1470-6.
2004: Kuyper L M; Lampinen T M; Li K; Spittal P M; Hogg R S; Schechter M T; Wood E
Factors associated with sex trade involvement among male participants in a prospective study of injection drug users.
Sexually transmitted infections 2004;80(6):531-5.
2004: Kuyper Laura M; Hogg Robert S; Montaner Julio S G; Schechter Martin T; Wood Evan
The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions.
Journal of urban health : bulletin of the New York Academy of Medicine 2004;81(4):655-60.
2004: Rusch Melanie; Nixon Stephanie; Schilder Arn; Braitstein Paula; Chan Keith; Hogg Robert S
Prevalence of activity limitation among persons living with HIV/AIDS in British Columbia.
Canadian journal of public health. Revue canadienne de santé publique 2004;95(6):437-40.
2004: Palepu Anita; Tyndall Mark W; Chan Keith; Wood Evan; Montaner Julio S G; Hogg Robert S
Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Antiviral therapy 2004;9(5):713-9.
2004: Rusch M; Nixon S; Schilder A; Braitstein P; Chan K; Hogg R S
Use of antiretroviral therapy among HIV positive individuals living in British Columbia.
AIDS care 2004;16(7):914-22.
2004: Anema Aranka; Chan Keith; McGuire Anna; Barer Justin M; Hogg Robert S
Is "3 by 5" enough? Recalculating the global need for antiretroviral treatment.
Lancet 2004;364(9439):1034-5.
2004: Wood Evan; Hogg Robert S; Bonner Simon; Kerr Thomas; Li Kathy; Palepu Anita; Guillemi Silvia; Schechter Martin T; Montaner Julio S G
Staging for antiretroviral therapy among HIV-infected drug users.
JAMA : the journal of the American Medical Association 2004;292(10):1175-7.
2004: Loutfy Mona R; Raboud Janet M; Walmsley Sharon L; Saskin Refik; Montaner Julio S; Hogg Robert S; Thompson Courtney A; Harrigan P Richard
Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimens.
Antiviral therapy 2004;9(4):595-602.
2004: Rusch Melanie; Lampinen Thomas M; Schilder Arn; Hogg Robert S
Unprotected anal intercourse associated with recreational drug use among young men who have sex with men depends on partner type and intercourse role.
Sexually transmitted diseases 2004;31(8):492-8.
2004: Ledergerber Bruno; Lundgren Jens D; Walker A Sarah; Sabin Caroline; Justice Amy; Reiss Peter; Mussini Cristina; Wit Ferdinand; d'Arminio Monforte Antonella; Weber Rainer; Fusco Gregory; Staszewski Schlomo; Law Matthew; Hogg Robert; Lampe Fiona; Gill M John; Castelli Francesco; Phillips Andrew N;
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
Lancet 2004;364(9428):51-62.
2004: Recsky Magdalena A; Brumme Zabrina L; Chan Keith J; Wynhoven Brian; Yip Benita; Dong Winnie W Y; Heath Katherine V; Montaner Julio S G; Levy Adrian R; Hogg Robert S; Harrigan P Richard
Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
The Journal of infectious diseases 2004;190(2):285-92.
2004: Kerr Thomas; Palepu Anita; Barness Gordon; Walsh John; Hogg Robert; Montaner Julio; Tyndall Mark; Wood Evan
Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Antiviral therapy 2004;9(3):407-14.
2004: Wood Evan; Spittal Patricia; Li Kathy; Kerr Thomas; Miller Cari L; Hogg Robert S; Montaner Julio S G; Schechter Martin T
Inability to access addiction treatment and risk of HIV infection among injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2004;36(2):750-4.
2004: Moore David M; Hogg Robert S
Trends in antenatal human immunodeficiency virus prevalence in Western Kenya and Eastern Uganda: evidence of differences in health policies?
International journal of epidemiology 2004;33(3):542-8.
2004: Castillo E; Palepu A; Beardsell A; Akagi L; Yip B; Montaner J S G; Hogg R S
Outpatient pharmacy care and HIV viral load response among patients on HAART.
AIDS care 2004;16(4):446-57.
2004: Wood Evan; Spittal Patricia M; Small Will; Kerr Thomas; Li Kathy; Hogg Robert S; Tyndall Mark W; Montaner Julio S G; Schechter Martin T
Displacement of Canada's largest public illicit drug market in response to a police crackdown.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2004;170(10):1551-6.
2004: Wood Evan; Montaner Julio S G; Yip Benita; Tyndall Mark W; Schechter Martin T; O'Shaughnessy Michael V; Hogg Robert S
Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users.
Antiviral therapy 2004;9(2):229-35.
2004: Wood Evan; Hogg Robert S; Yip Benita; Harrigan P Richard; Montaner Julio S G
Using baseline CD4 cell count and plasma HIV RNA to guide the initiation of highly active antiretroviral therapy.
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 2004;56(2):232-6.
2004: O'Connell Jacqueline M; Lampinen Thomas M; Weber Amy E; Chan Keith; Miller Mary Lou; Schechter Martin T; Hogg Robert S
Sexual risk profile of young men in Vancouver, British Columbia, who have sex with men and inject drugs.
AIDS and behavior 2004;8(1):17-23.
2004: Brumme Zabrina L; Dong Winnie W Y; Yip Benita; Wynhoven Brian; Hoffman Noah G; Swanstrom Ronald; Jensen Mark A; Mullins James I; Hogg Robert S; Montaner Julio S G; Harrigan P Richard
Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy.
AIDS (London, England) 2004;18(4):F1-9.
2004: Wood Evan; Hogg Robert S; Yip Benita; Harrigan P Richard; O'Shaughnessy Michael V; Montaner Julio S G
The impact of adherence on CD4 cell count responses among HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2004;35(3):261-8.
2004: Montaner Julio S G; Côté Hélène C F; Harris Marianne; Hogg Robert S; Yip Benita; Harrigan P Richard; O'Shaughnessy Michael V
Nucleoside-related mitochondrial toxicity among HIV-infected patients receiving antiretroviral therapy: insights from the evaluation of venous lactic acid and peripheral blood mitochondrial DNA.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38 Suppl 2():S73-9.
2004: Keenan Sean P; Dodek Peter; Chan Keith; Simon Mathieu; Hogg Robert S; Anis Aslam H; Spinelli John J; Tilley Jessica; Norena Monica; Wong Hubert
Intensive care unit survivors have fewer hospital readmissions and readmission days than other hospitalized patients in British Columbia.
Critical care medicine 2004;32(2):391-8.
2004: Rusch Melanie; Nixon Stephanie; Schilder Arn; Braitstein Paula; Chan Keith; Hogg Robert S
Impairments, activity limitations and participation restrictions: prevalence and associations among persons living with HIV/AIDS in British Columbia.
Health and quality of life outcomes 2004;2():46.
2003: O'Connell Jacqueline M; Braitstein Paula; Hogg Robert S; Yip Benito; Craib Kevin J P; O'Shaughnessy Michael V; Montaner Julio S G; Burdge David R
Age, adherence and injection drug use predict virological suppression among men and women enrolled in a population-based antiretroviral drug treatment programme.
Antiviral therapy 2003;8(6):569-76.
2003: Palepu Anita; Tyndall Mark W; Li Kathy; Yip Benita; O'Shaughnessy Michael V; Schechter Martin T; Montaner Julio S G; Hogg Robert S
Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.
Journal of urban health : bulletin of the New York Academy of Medicine 2003;80(4):667-75.
2003: Wood Evan; Hogg Robert S; Heath Katherine V; de la Rosa Rafael; Lee Nelson; Yip Benita; O'Shaughnessy Michael V O; Montaner Julio S G
Provider bias in the selection of non-nucleoside reverse transcriptase inhibitor and protease inhibitor-based highly active antiretroviral therapy and HIV treatment outcomes in observational studies.
AIDS (London, England) 2003;17(18):2629-34.
2003: Wood Evan; Hogg Robert S; Yip Benita; Quercia Romina; Harrigan P Richard; O'Shaughnessy Michael V; Montaner Julio S G
Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapy.
The Journal of infectious diseases 2003;188(10):1421-5.
2003: Wood Evan; Hogg Robert S; Yip Benita; Harrigan P Richard; O'Shaughnessy Michael V; Montaner Julio S G
Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
Annals of internal medicine 2003;139(10):810-6.
2003: Wood Evan; Hogg Robert S; Yip Benita; O'Shaughnessy Michael V; Montaner Julio S G
CD4 cell count response to nonnucleoside reverse transcriptase inhibitor- or protease inhibitor-based highly active antiretroviral therapy in an observational cohort study.
Journal of acquired immune deficiency syndromes (1999) 2003;34(3):347-8.
2003: Wood Evan; Montaner Julio S G; Bangsberg David R; Tyndall Mark W; Strathdee Steffanie A; O'Shaughnessy Michael V; Hogg Robert S
Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world.
AIDS (London, England) 2003;17(17):2419-27.
2003: Delgado Juan; Heath Katherine V; Yip Benita; Marion Stephen; Alfonso Victoria; Montaner Julio S G; O'Shaughnessy Michael V; Hogg Robert S
Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill.
Antiviral therapy 2003;8(5):471-8.
2003: Bedell Richard; Heath Katherine V; Hogg Robert S; Wood Evan; Press Natasha; Yip Benita; O'Shaughnessy Michael V; Montaner Julio S G
Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Antiviral therapy 2003;8(5):379-84.
2003: Wood Evan; Montaner Julio S G; Tyndall Mark W; Schechter Martin T; O'Shaughnessy Michael V; Hogg Robert S
Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy.
The Journal of infectious diseases 2003;188(8):1164-70.
2003: Montaner Julio S G; Côté Hélène C F; Harris Marianne; Hogg Robert S; Yip Benita; Chan Jennifer W; Harrigan P Richard; O'Shaughnessy Michael V
Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2003;34 Suppl 1():S85-90.
2003: Wood Evan; Montaner Julio S G; Yip Benita; Tyndall Mark W; Schechter Martin T; O'Shaughnessy Michael V; Hogg Robert S
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;169(7):656-61.
2003: Braitstein Paula; Yip Benita; Heath Katherine V; Levy Adrian R; Montaner Julio S; Humphries Karin; Kiely F Michael; O'Shaughnessy Michael V; Hogg Robert S
Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000.
AIDS (London, England) 2003;17(14):2071-5.
2003: Barer Justin M; McGuire Anna; Hogg Robert S
Fast track to Atlantis.
Journal of urban health : bulletin of the New York Academy of Medicine 2003;80(3):361-2.
2003: Chêne G; Sterne J A C; May M; Costagliola D; Ledergerber B; Phillips A N; Dabis F; Lundgren J; D'Arminio Monforte A; de Wolf F; Hogg R; Reiss P; Justice A; Leport C; Staszewski S; Gill J; Fatkenheuer G; Egger M E;
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.
Lancet 2003;362(9385):679-86.
2003: Alexander Christopher S; Asselin Jérôme J; Ting Lillian S L; Montaner Julio S G; Hogg Robert S; Yip Benita; O'Shaughnessy Michael V; Harrigan P Richard
Antiretroviral concentrations in untimed plasma samples predict therapy outcome in a population with advanced disease.
The Journal of infectious diseases 2003;188(4):541-8.
2003: Braitstein Paula; Li Kathy; Tyndall Mark; Spittal Patricia; O'Shaughnessy Michael V; Schilder Arn; Johnston Caitlin; Hogg Robert S; Schechter Martin T
Sexual violence among a cohort of injection drug users.
Social science & medicine (1982) 2003;57(3):561-9.
2003: Lee Nelson; Hogg Robert S; Yip Benita; Harrigan P Richard; Harris Marianne; O'Shaughnessy Michael V; Montaner Julio S G
Rates of disease progression among human immunodeficiency virus-infected persons initiating multiple-drug rescue therapy.
The Journal of infectious diseases 2003;188(1):137-41.
2003: Côté Hélène C F; Yip Benita; Asselin Jérôme J; Chan Jennifer W; Hogg Robert S; Harrigan P Richard; O'Shaughnessy Michael V; Montaner Julio S G
Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens.
The Journal of infectious diseases 2003;187(12):1972-6.
2003: Brumme Zabrina L; Chan Keith J; Dong Winnie W Y; Wynhoven Brian; Mo Theresa; Hogg Robert S; Montaner Julio S G; O'Shaughnessy Michael V; Harrigan P Richard
Prevalence and clinical implications of insertions in the HIV-1 p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapy.
Antiviral therapy 2003;8(2):91-6.
2003: Palepu Anita; Tyndall Mark; Yip Benita; O'Shaughnessy Michael V; Hogg Robert S; Montaner Julio S G
Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use.
Journal of acquired immune deficiency syndromes (1999) 2003;32(5):522-6.
2003: Keenan Sean P; Dodek Peter; Chan Keith; Hogg Robert S; Craib Kevin J P; Anis Aslam H; Spinelli John J
Length of ICU stay for chronic obstructive pulmonary disease varies among large community hospitals.
Intensive care medicine 2003;29(4):590-5.
2003: Hogg Robert S; Craib Kevin J P; Pi David; Lee Samuel S; Minuk Gerald Y; Shapiro Colin M; Schechter Martin T; O'Shaughnessy Michael V
Health and socioeconomic status differences among antibody hepatitis C positive and negative transfusion recipients, 1986-1990.
Canadian journal of public health. Revue canadienne de santé publique 2003;94(2):130-4.
2003: Weber Amy E; Craib Kevin J; Chan Keith; Martindale Steve; Miller Mary Lou; Cook Darrel A; Schechter Martin T; Hogg Robert S
Determinants of HIV serconversion in an era of increasing HIV infection among young gay and bisexual men.
AIDS (London, England) 2003;17(5):774-7.
2003: Wood Evan; Hogg Robert S; Yip Benita; Harrigan P Richard; O'Shaughnessy Michael V; Montaner Julio S G
Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?
AIDS (London, England) 2003;17(5):711-20.
2003: Brumme Zabrina L; Dong Winnie W Y; Chan Keith J; Hogg Robert S; Montaner Julio S G; O'Shaughnessy Michael V; Harrigan P Richard
Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response.
AIDS (London, England) 2003;17(2):201-8.
2003: Wood Evan; Tyndall Mark W; Spittal Patricia M; Li Kathy; Anis Aslam H; Hogg Robert S; Montaner Julio S G; O'Shaughnessy Michael V; Schechter Martin T
Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;168(2):165-9.
2003: Heath K V; Montaner J S G; Bondy G; Singer J; O'Shaughnessy M V; Hogg R S
Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection.
Current drug targets 2003;4(1):13-22.
2003: Ratner Pamela A; Johnson Joy L; Shoveller Jean A; Chan Keith; Martindale Steve L; Schilder Arn J; Botnick Michael R; Hogg Robert S
Non-consensual sex experienced by men who have sex with men: prevalence and association with mental health.
Patient education and counseling 2003;49(1):67-74.
2003: Craib Kevin J P; Spittal Patricia M; Wood Evan; Laliberte Nancy; Hogg Robert S; Li Kathy; Heath Katherine; Tyndall Mark W; O'Shaughnessy Michael V; Schechter Martin T
Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;168(1):19-24.
2003: Wood Evan; Kerr Thomas; Spittal Patricia M; Li Kathy; Small Will; Tyndall Mark W; Hogg Robert S; O'Shaughnessy Michael V; Schechter Martin T
The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2003;32(1):2-8.
2003: Hogg Robert S
Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania Pujades, by Rodríguez et al.
AIDS (London, England) 2003;17 Suppl 4():S128-30.
2003: Hogg Robert S
Effects of CCR5-delta32 and CCR2-641 alleles on HIV-1 disease progression: the protection varies with duration of infection, by Mulherin et al.
AIDS (London, England) 2003;17 Suppl 4():S127-8.
2003: Hogg Robert S
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants, by Dowling et al.
AIDS (London, England) 2003;17 Suppl 4():S125-7.
2002: Press Natasha; Tyndall Mark W; Wood Evan; Hogg Robert S; Montaner Julio S G
Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence.
Journal of acquired immune deficiency syndromes (1999) 2002;31 Suppl 3():S112-7.
2002: O'Connell Jacqueline M; Hogg Robert S; Chan Keith; Strathdee Steffanie A; McLean Nancy; Martindale Steve L; Willoughby Brian; Remis Robert
Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
Journal of acquired immune deficiency syndromes (1999) 2002;31(5):521-8.
2002: Harris Marianne; Chan Keith J; Tesiorowski Alicja M; Hogg Robert S; Rosenberg Frances M; Yan Clifford Chan; Montaner Julio S G
Random venous lactate levels among HIV-positive patients on antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;31(4):448-50.
2002: Hogg Robert; Cahn Pedro; Katabira Elly T; Lange Joep; Samuel N M; O'Shaughnessy Michael; Vella Stefano; Wainberg Mark A; Montaner Julio
Time to act: global apathy towards HIV/AIDS is a crime against humanity.
Lancet 2002;360(9347):1710-1.
2002: Heath Katherine V; Chan Keith J; Singer Joel; O'Shaughnessy Michael V; Montaner Julio S G; Hogg Robert S
Incidence of morphological and lipid abnormalities: gender and treatment differentials after initiation of first antiretroviral therapy.
International journal of epidemiology 2002;31(5):1016-20.
2002: Heath Katherine V; Singer Joel; O'Shaughnessy Michael V; Montaner Julio S G; Hogg Robert S
Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;31(2):211-7.
2002: Wood Evan; Montaner Julio S G; Chan Keith; Tyndall Mark W; Schechter Martin T; Bangsberg David; O'Shaughnessy Michael V; Hogg Robert S
Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
AIDS (London, England) 2002;16(15):2065-72.
2002: Kerr Thomas; Craib Kevin J; Gataric Nada; Hogg Robert S
Assessing the impact of an adult day program on hospital utilization by persons living with HIV/AIDS.
Journal of acquired immune deficiency syndromes (1999) 2002;31(1):117-9.
2002: Brumme Zabrina L; Chan Keith J; Dong Winnie W; Mo Theresa; Wynhoven Brian; Hogg Robert S; Montaner Julio S; O'Shaughnessy Michael V; Harrigan P Richard
No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.
AIDS (London, England) 2002;16(14):1929-33.
2002: Chan Kenny C W; Yip Benita; Hogg Robert S; Montaner Julio S G; O'Shaughnessy Michael V
Survival rates after the initiation of antiretroviral therapy stratified by CD4 cell counts in two cohorts in Canada and the United States.
AIDS (London, England) 2002;16(12):1693-5.
2002: Heath Katherine V; Hogg Robert S; Singer Joel; Chan Keith J; O'Shaughnessy Michael V; Montaner Julio S G
Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort.
Journal of acquired immune deficiency syndromes (1999) 2002;30(4):440-7.
2002: Egger Matthias; May Margaret; Chêne Geneviève; Phillips Andrew N; Ledergerber Bruno; Dabis François; Costagliola Dominique; D'Arminio Monforte Antonella; de Wolf Frank; Reiss Peter; Lundgren Jens D; Justice Amy C; Staszewski Schlomo; Leport Catherine; Hogg Robert S; Sabin Caroline A; Gill M John; Salzberger Bernd; Sterne Jonathan A C;
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
Lancet 2002;360(9327):119-29.
2002: Wood Evan; Hogg Robert S; Yip Benita; Tyndall Mark W; Sherlock Christopher H; Harrigan Richard P; O'Shaughnessy Michael V; Montaner Julio S G
"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;30(2):159-66.
2002: Braitstein Paula; Chan Keith; Beardsell Ann; McLeod Alistair; Montaner Julio S G; O'Shaughnessy Michael V; Hogg Robert S
Prescribing practices in a population-based HIV postexposure prophylaxis program.
AIDS (London, England) 2002;16(7):1067-70.
2002: Hogg Robert S; Heath Katherine; Bangsberg David; Yip Benita; Press Natasha; O'Shaughnessy Michael V; Montaner Julio S G
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.
AIDS (London, England) 2002;16(7):1051-8.
2002: Braitstein Paula; Chan Keith; Beardsell Ann; McLeod Alistair; Montaner Julio S G; O'Shaughnessy Michael V; Hogg Robert S
Safety and tolerability of combination antiretroviral post-exposure prophylaxis in a population-based setting.
Journal of acquired immune deficiency syndromes (1999) 2002;29(5):547-8.
2002: Wood Evan; Tyndall Mark W; Spittal Patricia M; Li Kathy; Hogg Robert S; Montaner Julio S G; O'Shaughnessy Michael V; Schechter Martin T
Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme.
AIDS (London, England) 2002;16(6):941-3.
2002: Keenan Sean P; Dodek Peter; Chan Keith; Hogg Robert S; Craib Kevin J P; Anis Aslam H; Spinelli John J
Intensive care unit admission has minimal impact on long-term mortality.
Critical care medicine 2002;30(3):501-7.
2002: Schilder Ann; Spittal Patricia; Hogg Robert
"Coming out" is a dangerous time: HIV among young gay men.
Focus (San Francisco, Calif.) 2002;17(4):1-4.
2002: Hogg Robert S; Havlir Diane; Miller Veronica; Montaner Julio S G
To stop or not to stop: that is the question, but what is the answer?
AIDS (London, England) 2002;16(5):787-9.
2002: Low-Beer S; Bartholomew K; Weber A E; Chan K; Landolt M; Oram D; Schilder A; Hogg R
A demographic and health profile of gay and bisexual men in a large Canadian urban setting.
AIDS care 2002;14(1):111-5.
2002: Phillips Peter; Chan Keith; Hogg Robert; Bessuille Elaine; Black William; Talbot James; O'Shaughnessy Michael; Montaner Julio
Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(3):371-8.
2002: Botnick Michael R; Heath Katherine V; Cornelisse Peter G A; Strathdee Steffanie A; Martindale Stephen L; Hogg Robert S
Correlates of suicide attempts in an open cohort of young men who have sex with men.
Canadian journal of public health. Revue canadienne de santé publique 2002;93(1):59-62.
2001: Hogg R S; Strathdee S A; Craib K J; O'Shaughnessy M V; Montaner J; Schechter M T
Gay life expectancy revisited.
International journal of epidemiology 2001;30(6):1499.
2001: Weber A E; Craib K J; Chan K; Martindale S; Miller M L; Schechter M T; Hogg R S
Sex trade involvement and rates of human immunodeficiency virus positivity among young gay and bisexual men.
International journal of epidemiology 2001;30(6):1449-54; discussion 1455-6.
2001: Montaner J S; Harris M; Harrigan R; Hogg R; Wood E
A compromise strategy for patients with multiple drug failure.
AIDS (London, England) 2001;15(18):2470.
2001: Hogg R S; Yip B; Chan K J; Wood E; Craib K J; O'Shaughnessy M V; Montaner J S
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
JAMA : the journal of the American Medical Association 2001;286(20):2568-77.
2001: Braitstein P; Chan K; Beardsell A; McLeod A; Montaner J S; O'Shaughnessy M V; Hogg R S
Another reality check: the direct costs of providing post-exposure prophylaxis in a population-based programme.
AIDS (London, England) 2001;15(17):2345-7.
2001: Brumme Z L; Chan K J; Dong W; Hogg R; O'Shaughnessy M V; Montaner J S; Harrigan P R
CCR5Delta32 and promoter polymorphisms are not correlated with initial virological or immunological treatment response.
AIDS (London, England) 2001;15(17):2259-66.
2001: Lacaille D; Hogg R S
The effect of arthritis on working life expectancy.
The Journal of rheumatology 2001;28(10):2315-9.
2001: Piaseczna M A; Craib K J; Li K; Chan K; Weber A E; Strathdee S A; Martindale S; Schechter M T; Hogg R S
Longitudinal patterns of sexual behavior and condom use in a cohort of HIV-negative gay and bisexual men in Vancouver, British Columbia, Canada, 1995-2000.
Journal of acquired immune deficiency syndromes (1999) 2001;28(2):187-93.
2001: Weber A E; Chan K; George C; Hogg R S; Remis R S; Martindale S; Otis J; Miller M L; Vincelette J; Craib K J; Mâsse B; Schechter M T; LeClerc R; Lavoie R; Turmel B; Parent R; Alary M
Risk factors associated with HIV infection among young gay and bisexual men in Canada.
Journal of acquired immune deficiency syndromes (1999) 2001;28(1):81-8.
2001: Wood E; Tyndall M W; Spittal P M; Li K; Kerr T; Hogg R S; Montaner J S; O'Shaughnessy M V; Schechter M T
Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2001;165(4):405-10.
2001: Hogg R S; Weber A E; Chan K; Martindale S; Cook D; Miller M L; Craib K J
Increasing incidence of HIV infections among young gay and bisexual men in Vancouver.
AIDS (London, England) 2001;15(10):1321-2.
2001: Schilder A J; Kennedy C; Goldstone I L; Ogden R D; Hogg R S; O'Shaughnessy M V
"Being dealt with as a whole person." Care seeking and adherence: the benefits of culturally competent care.
Social science & medicine (1982) 2001;52(11):1643-59.
2001: Dodek P; Chan K; Simon M; Hogg R
Is it health care or is it health?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2001;164(7):968.
2001: Braitstein P; Kendall T; Chan K; Wood E; Montaner J S; O'Shaughnessy M V; Hogg R S
Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents.
AIDS (London, England) 2001;15(4):532-3.
2001: Palepu A; Yip B; Miller C; Strathdee S A; O'Shaughnessy M V; Montaner J S; Hogg R S
Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use.
AIDS (London, England) 2001;15(3):423-4.
2001: Heath K V; Hogg R S; Chan K J; Harris M; Montessori V; O'Shaughnessy M V; Montanera J S
Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database.
AIDS (London, England) 2001;15(2):231-9.
2001: Montaner J S; Harrigan P R; Jahnke N; Raboud J; Castillo E; Hogg R S; Yip B; Harris M; Montessori V; O'Shaughnessy M V
Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimens.
AIDS (London, England) 2001;15(1):61-9.
2000: Anis A H; Guh D; Hogg R S; Wang X H; Yip B; Craib K J; O'Shaughnessy M V; Schechter M T; Montaner J S
The cost effectiveness of antiretroviral regimens for the treatment of HIV/AIDS.
PharmacoEconomics 2000;18(4):393-404.
2000: Wood E; Yip B; Hogg R S; Sherlock C H; Jahnke N; Harrigan R P; O'Shaughnessy M V; Montaner J S
Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy.
AIDS (London, England) 2000;14(13):1955-60.
2000: Wood E; Chan K; Montaner J S; Schechter M T; Tyndall M; O'Shaughnessy M V; Hogg R S
The end of the line: has rapid transit contributed to the spatial diffusion of HIV in one of Canada's largest metropolitan areas?
Social science & medicine (1982) 2000;51(5):741-8.
2000: Wood E; Braitstein P; Montaner J S; Schechter M T; Tyndall M W; O'Shaughnessy M V; Hogg R S
Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa.
Lancet 2000;355(9221):2095-100.
2000: Wood E; Schechter M T; Tyndall M W; Montaner J S; O'Shaughnessy M V; Hogg R S
Antiretroviral medication use among injection drug users: two potential futures.
AIDS (London, England) 2000;14(9):1229-35.
2000: Heacock H; Hertzman C; Demers P A; Gallagher R; Hogg R S; Teschke K; Hershler R; Bajdik C D; Dimich-Ward H; Marion S A; Ostry A; Kelly S
Childhood cancer in the offspring of male sawmill workers occupationally exposed to chlorophenate fungicides.
Environmental health perspectives 2000;108(6):499-503.
2000: Low-Beer S; Yip B; O'Shaughnessy M V; Hogg R S; Montaner J S
Adherence to triple therapy and viral load response.
Journal of acquired immune deficiency syndromes (1999) 2000;23(4):360-1.
2000: Low-Beer S; Chan K; Yip B; Wood E; Montaner J S; O'Shaughnessy M V; Hogg R S
Depressive symptoms decline among persons on HIV protease inhibitors.
Journal of acquired immune deficiency syndromes (1999) 2000;23(4):295-301.
2000: Wood E; Low-Beer S; Bartholomew K; Landolt M; Oram D; O'Shaughnessy M V; Hogg R S
Modern antiretroviral therapy improves life expectancy of gay and bisexual males in Vancouver's West End.
Canadian journal of public health. Revue canadienne de santé publique 2000;91(2):125-8.
2000: Weber A E; Yip B; O'Shaughnessy M V; Montaner J S; Hogg R S
Determinants of hospital admission among HIV-positive people in British Columbia.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000;162(6):783-6.
2000: Wood E; Yip B; Gataric N; Montaner J S; O'Shaughnessy M V; Schechter M T; Hogg R S
Determinants of geographic mobility among participants in a population-based HIV/AIDS drug treatment program.
Health & place 2000;6(1):33-40.
2000: Low-Beer S; Weber A E; Bartholomew K; Landolt M; Oram D; Montaner J S; O'Shaughnessy M V; Hogg R S
A reality check: the cost of making post-exposure prophylaxis available to gay and bisexual men at high sexual risk.
AIDS (London, England) 2000;14(3):325-6.
2000: Craib K J; Weber A C; Cornelisse P G; Martindale S L; Miller M L; Schechter M T; Strathdee S A; Schilder A; Hogg R S
Comparison of sexual behaviors, unprotected sex, and substance use between two independent cohorts of gay and bisexual men.
AIDS (London, England) 2000;14(3):303-11.
2000: Strathdee S A; Martindale S L; Cornelisse P G; Miller M L; Craib K J; Schechter M T; O'Shaughnessy M V; Hogg R S
HIV infection and risk behaviours among young gay and bisexual men in Vancouver.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000;162(1):21-5.
2000: Cornelisse P G; Montessori V; Yip B; Craib K J; O'Shaughnessy M V; Montaner J S; Hogg R S
The impact of zidovudine on dementia-free survival in a population of HIV-positive men and women on antiretroviral therapy.
International journal of STD & AIDS 2000;11(1):52-6.
2000: Low-Beer S; Chan K; Wood E; Yip B; Montaner J S; O'Shaughnessy M V; Hogg R S
Health related quality of life among persons with HIV after the use of protease inhibitors.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2000;9(8):941-9.
1999: Palepu A; Strathdee S A; Hogg R S; Anis A H; Rae S; Cornelisse P G; Patrick D M; O'Shaughnessy M V; Schechter M T
The social determinants of emergency department and hospital use by injection drug users in Canada.
Journal of urban health : bulletin of the New York Academy of Medicine 1999;76(4):409-18.
1999: Weber A E; Alakawaf R; Montaner J S; O'Shaughnessy M V; Hogg R S
Bitter pill: the current state of antiretroviral care in selected nations around the globe.
AIDS (London, England) 1999;13(17):2481-2.
1999: Heath K V; Wood E; Bally G; Cornelisse P G; Hogg R S
Experience in treating persons with HIV/AIDS and the legalization of assisted suicide: the views of Canadian physicians.
AIDS care 1999;11(5):501-10.
1999: Harrigan P R; Hertogs K; Verbiest W; Pauwels R; Larder B; Kemp S; Bloor S; Yip B; Hogg R; Alexander C; Montaner J S
Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting.
AIDS (London, England) 1999;13(14):1863-71.
1999: Raboud J M; Rae S; Hogg R S; Yip B; Sherlock C H; Harrigan P R; O'Shaughnessy M V; Montaner J S
Suppression of plasma virus load below the detection limit of a human immunodeficiency virus kit is associated with longer virologic response than suppression below the limit of quantitation.
The Journal of infectious diseases 1999;180(4):1347-50.
1999: Heath K V; Cornelisse P G; Strathdee S A; Palepu A; Miller M L; Schechter M T; O'Shaughnessy M V; Hogg R S
HIV-associated risk factors among young Canadian Aboriginal and non-Aboriginal men who have sex with men.
International journal of STD & AIDS 1999;10(9):582-7.
1999: Jahnke N; Yip B; Hogg R S; O'Shaughnessy M; Montaner J S
Antiviral effect of AZT versus stavudine in combination with lamivudine and indinavir in the context of a populational study.
Journal of acquired immune deficiency syndromes (1999) 1999;21(4):347-8.
1999: Kirstein L M; Mellors J W; Rinaldo C R; Margolick J B; Giorgi J V; Phair J P; Dietz E; Gupta P; Sherlock C H; Hogg R; Montaner J S; Muñoz A
Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma.
Journal of clinical microbiology 1999;37(8):2428-33.
1999: Wood E; Sallar A M; Schechter M T; Hogg R S
Social inequalities in male mortality amenable to medical intervention in British Columbia.
Social science & medicine (1982) 1999;48(12):1751-8.
1999: Weber A E; Hogg R S
Morbidity and mortality related to human immunodeficiency virus in Canadian men and women, 1987-94.
Canadian journal of public health. Revue canadienne de santé publique 1999;90(2):127-32.
1999: Montaner J S; Montessori V; Harrigan R; O'Shaughnessy M; Hogg R
Antiretroviral therapy: 'the state of the art'.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1999;53(2):63-72.
1999: Hogg R S; Yip B; Kully C; Craib K J; O'Shaughnessy M V; Schechter M T; Montaner J S
Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;160(5):659-65.
1999: Jahnke N; Seminari E; Hogg R S; Yip B; O'Shaughnessy M V; Montaner J S
Antiretroviral effect of two different dose regimens of ritonavir and saquinavir on HIV-infected adults in a population-based setting.
Antiviral therapy 1999;4(3):151-6.
1998: Forrest D M; Seminari E; Hogg R S; Yip B; Raboud J; Lawson L; Phillips P; Schechter M T; O'Shaughnessy M V; Montaner J S
The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(6):1379-85.
1998: Montaner J S; Hogg R; Raboud J; Harrigan R; O'Shaughnessy M
Antiretroviral treatment in 1998.
Lancet 1998;352(9144):1919-22.
1998: Hogg R S; Weber A E; Craib K J; Anis A H; O'Shaughnessy M V; Schechter M T; Montaner J S
One world, one hope: the cost of providing antiretroviral therapy to all nations.
AIDS (London, England) 1998;12(16):2203-9.
1998: Raboud J M; Seminari E; Rae S L; Harrigan P R; Hogg R S; Conway B; Sherlock C; Schechter M T; O'Shaughnessy M V; Montaner J S
Comparison of costs of strategies for measuring levels of human immunodeficiency virus type 1 RNA in plasma by using Amplicor and Ultra Direct assays.
Journal of clinical microbiology 1998;36(11):3369-71.
1998: Veugelers P J; Cornelisse P G; Craib K J; Marion S A; Hogg R S; Strathdee S A; Montaner J S; O'Shaughnessy M V; Schechter M T
Models of survival in HIV infection and their use in the quantification of treatment benefits.
American journal of epidemiology 1998;148(5):487-96.
1998: Strathdee S A; Hogg R S; Martindale S L; Cornelisse P G; Craib K J; Montaner J S; O'Shaughnessy M V; Schechter M T
Determinants of sexual risk-taking among young HIV-negative gay and bisexual men.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(1):61-6.
1998: Rhone S A; Hogg R S; Yip B; Sherlock C; Conway B; Schechter M T; O'Shaughnessy M V; Montaner J S
Do dual nucleoside regimens have a role in an era of plasma viral load-driven antiretroviral therapy?
The Journal of infectious diseases 1998;178(3):662-8.
1998: Heath K V; Frank O; Montaner J S; O'Shaughnessy M V; Schechter M T; Hogg R S
Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) mortality in industrialized nations, 1987-1991.
International journal of epidemiology 1998;27(4):685-90.
1998: Strathdee S A; Palepu A; Cornelisse P G; Yip B; O'Shaughnessy M V; Montaner J S; Schechter M T; Hogg R S
Barriers to use of free antiretroviral therapy in injection drug users.
JAMA : the journal of the American Medical Association 1998;280(6):547-9.
1998: Anis A H; Hogg R S; Wang X H; Yip B; Palepu A; Montaner J S; O'Shaughnessy M V; Schechter M T
Modelling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy.
PharmacoEconomics 1998;13(6):697-705.
1998: Needham D M; Hogg R S; Yip B; O'Shaughnessy M; Schechter M T; Montaner J S
The impact of antiretroviral therapy on AIDS survival observed in a province-wide drug treatment programme.
International journal of STD & AIDS 1998;9(6):370-2.
1998: Rhone S A; Hogg R S; Yip B; Sherlock C; Conway B; Schechter M T; O'Shaughnessy M V; Montaner J S
The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study.
AIDS (London, England) 1998;12(6):619-24.
1998: Montaner J S; Hogg R S; Weber A E; Anis A H; O'Shaughnessy M V; Schechter M T
The costs of triple-drug anti-HIV therapy for adults in the Americas.
JAMA : the journal of the American Medical Association 1998;279(16):1263-4.
1998: Anis A H; Hogg R S; Yip B; Wang X H; Montaner J S; O'Shaughnessy M V; Schechter M T
Average annual drug cost and its determinants in a population based cohort of HIV-positive adult men and women.
PharmacoEconomics 1998;13(3):327-36.
1998: Hogg R S; Rhone S A; Yip B; Sherlock C; Conway B; Schechter M T; O'Shaughnessy M V; Montaner J S
Antiviral effect of double and triple drug combinations amongst HIV-infected adults: lessons from the implementation of viral load-driven antiretroviral therapy.
AIDS (London, England) 1998;12(3):279-84.
1998: Hogg R S; Raboud J; Bigham M; Montaner J S; O'Shaughnessy M; Schechter M T
Relation between hospital HIV/AIDS caseload and mortality among persons with HIV/AIDS in Canada.
Clinical and investigative medicine. Médecine clinique et experimentale 1998;21(1):27-32.
1998: Hogg R S; Heath K V; Yip B; Craib K J; O'Shaughnessy M V; Schechter M T; Montaner J S
Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.
JAMA : the journal of the American Medical Association 1998;279(6):450-4.
1998: Heacock H; Hogg R; Marion S A; Hershler R; Teschke K; Dimich-Ward H; Demers P; Kelly S; Ostry A; Hertzman C
Fertility among a cohort of male sawmill workers exposed to chlorophenate fungicides.
Epidemiology (Cambridge, Mass.) 1998;9(1):56-60.
1997: Kim A L; Lim B K; Willoughby B; Hogg R S; Schechter M T; O'Shaughnessy M V; Montaner J S
Medical clinic utilization and patient characteristics at the XI International Conference on AIDS.
International journal of STD & AIDS 1997;8(12):799-800.
1997: Heath K V; Hogg R S; Singer J; Schechter M T; O'Shaughnessy M V; Montaner J S
Adherence to clinical guidelines for the therapeutic management of HIV disease.
Clinical and investigative medicine. Médecine clinique et experimentale 1997;20(6):381-7.
1997: Heath K; Hogg R S; Raboud J; Montaner J S; O'Shaughnessy M; Schechter M T
Gender differentials in patterns of hospitalization for persons with HIV/AIDS.
AIDS (London, England) 1997;11(14):1788-9.
1997: Hogg R S; Anis A; Weber A E; O'Shaughnessy M V; Schechter M T
Triple-combination antiretroviral therapy in sub-Saharan Africa.
Lancet 1997;350(9088):1406.
1997: Heath K; Hogg R S; Singer J; Schechter M T; O'Shaughnessy M V; Montaner J S
Physician concurrence with primary care guidelines for persons with HIV disease.
International journal of STD & AIDS 1997;8(10):609-13.
1997: Heath K V; Bally G; Yip B; O'Shaughnessy M V; Hogg R S
HIV/AIDS care giving physicians: their experience and practice patterns.
International journal of STD & AIDS 1997;8(9):570-5.
1997: Craib K J; Strathdee S A; Hogg R S; Leung B; Montaner J S; O'Shaughnessy M V; Schechter M T
Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: a predictor of long-term mortality in HIV infection.
The Journal of infectious diseases 1997;176(3):798-800.
1997: Ostrow M J; Cornelisse P G; Heath K V; Craib K J; Schechter M T; O'Shaughnessy M; Montaner J S; Hogg R S
Determinants of complementary therapy use in HIV-infected individuals receiving antiretroviral or anti-opportunistic agents.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(2):115-20.
1997: Hogg R S; Strathdee S A; Craib K J; O'Shaughnessy M V; Montaner J S; Schechter M T
Modelling the impact of HIV disease on mortality in gay and bisexual men.
International journal of epidemiology 1997;26(3):657-61.
1997: Hogg R S; O'Shaughnessy M V; Gataric N; Yip B; Craib K; Schechter M T; Montaner J S
Decline in deaths from AIDS due to new antiretrovirals.
Lancet 1997;349(9061):1294.
1997: Montaner J S; Hogg R S; O'Shaughnessy M V
Emerging international consensus for use of antiretroviral therapy.
Lancet 1997;349(9058):1042.
1997: Hogg R S; Whitehead J; Ricketts M; Heath K V; Ng E; Lalonde P; Schechter M T
Patterns of geographic mobility of persons with AIDS in Canada from time of AIDS index diagnosis to death.
Clinical and investigative medicine. Médecine clinique et experimentale 1997;20(2):77-83.
1996: Montaner J S; Hogg R; Srour L F; Murphy C; Barber C G; Phillips P; O'Shaughnessy M; Schechter M T
Should we embrace new drugs with open arms? Experience from a community-based, open-arm, randomized clinical trial of combination antiretroviral therapy in advanced HIV disease.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;13(5):422-6.
1996: Pattullo A L; Hogg R S; Schilder A; Goldstone I L; Sussel R; O'Shaughnessy M V
Heterogeneity of care for HIV-infected individuals decreases with the physician knowledge.
International journal of STD & AIDS 1996;7(6):435-8.
1996: Montaner J S; Hogg R S; Heath K V; Phillips P; Craib K J; Schechter M T; O'Shaughnessy M V
Heterogeneity of physician agreement with recommended therapeutic guidelines for the management of HIV-associated disease.
Antiviral therapy 1996;1(3):157-66.
1996: Hogg R S; Heath K V; Strathdee S A; Montaner J S; O'Shaughnessy M V; Schechter M T
HIV/AIDS mortality in Canada: evidence of gender, regional and local area differentials.
AIDS (London, England) 1996;10(8):889-94.
1996: Mandigo K; Hogg R S; Phillips P; Barber C; Le T; Bessuille E; Black W; O'Shaughnessy M V; Schechter M T; Montaner J S
Pattern of utilization of rifabutin for prophylaxis of Mycobacterium avium complex among patients with advanced human immunodeficiency virus disease in a community setting.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1996;77(3):233-8.
1996: Strathdee S A; Hogg R S; O'Shaughnessy M V; Montaner J S; Schechter M T
A decade of research on the natural history of HIV infection: Part 2. Cofactors.
Clinical and investigative medicine. Médecine clinique et experimentale 1996;19(2):121-30.
1996: Montaner J S; Hogg R S; Yip B; Gataric N; Schechter M T; O'Shaughnessy M V
Increased zidovudine prescribing associated with lamivudine availability.
JAMA : the journal of the American Medical Association 1996;275(8):598.
1996: Sallar A M; Hogg R S; Schechter M T
Survival after age 80.
The New England journal of medicine 1996;334(8):537-8.
1996: Hogg R S; Craib K; Montaner J S; Schechter M T
Race, sex, drug use, and human immunodeficiency virus disease.
The New England journal of medicine 1996;334(2):123; author reply 123-4.
1995: Hogg R S; Schechter M T; Schilder A; Le R; Strathdee S A; Goldstone I L; O'Shaughnessy M V
Access to health care and geographic mobility of HIV/AIDS patients.
AIDS patient care 1995;9(6):297-302.
1995: Strathdee S A; Craib K J; Hogg R S; O'Shaughnessy M V; Montaner J S; Schechter M T
Long-term non-progression in HIV infection.
Lancet 1995;346(8986):1372.
1995: Hogg R S; Zadra J N; Chan-Yan C; Voigt R; Craib K J; Korosi-Ronco J; Montaner J S; Schechter M T
Analysis of nutritional intake in a cohort of homosexual men.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;9(2):162-7.
1995: Craib K J; Meddings D R; Strathdee S A; Hogg R S; Montaner J S; O'Shaughnessy M V; Schechter M T
Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men.
Genitourinary medicine 1995;71(3):150-4.
1995: Montaner J S; Strathdee S A; Veugelers P J; Hogg R S; Schechter M T
Incidence of endobronchial Kaposi's sarcoma.
Chest 1995;107(3):886.
1994: Hogg R S
HIV mortality linked to income.
Nursing standard (Royal College of Nursing (Great Britain) : 1987) 1994;9(6):12.
1994: Hogg R S
Variability in behavioural risk factors for heart disease in an Australian aboriginal community.
Journal of biosocial science 1994;26(4):539-51.
1994: Hogg R S; Strathdee S A; Craib K J; O'Shaughnessy M V; Montaner J S; Schechter M T
Lower socioeconomic status and shorter survival following HIV infection.
Lancet 1994;344(8930):1120-4.
1994: Hanvelt R A; Ruedy N S; Hogg R S; Strathdee S; Montaner J S; O'Shaughnessy M V; Schechter M T
Indirect costs of HIV/AIDS mortality in Canada.
AIDS (London, England) 1994;8(10):F7-11.
1994: Montaner J S; Le T; Hogg R; Ricketts M; Sutherland D; Strathdee S A; O'Shaughnessy M; Schechter M T
The changing spectrum of AIDS index diseases in Canada.
AIDS (London, England) 1994;8(5):693-6.
1994: Montaner J S; Hogg R S; Le R; O'Shaughnessy M V; Schechter M T
Rates of prescribing zidovudine post Concorde Trial.
JAMA : the journal of the American Medical Association 1994;271(16):1239.
1994: Hogg R S; Schechter M T; Montaner J S; Goldstone I; Craib K; O'Shaughnessy M V
Impact of HIV infection and AIDS on death rates in British Columbia and Canada.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1994;150(5):711-7.
1994: Schechter M T; Hogg R S; Aylward B; Craib K J; Le T N; Montaner J S
Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care.
Journal of clinical epidemiology 1994;47(1):59-67.
1993: Hogg R S; Craib K J; Willoughby B; Sestak P; Montaner J S; Schechter M T
Sociodemographic correlates for risk-taking behaviour among HIV seronegative homosexual men.
Canadian journal of public health. Revue canadienne de santé publique 1993;84(6):423-6.
1992: Hogg R S
Indigenous mortality: placing Australian aboriginal mortality within a broader context.
Social science & medicine (1982) 1992;35(3):335-46.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hogg Robert

Research Profile (preview)

Disorders

Geographic Areas

Procedures

Chemicals & Drugs

Concepts & Ideas

Living Beings

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hogg Robert (preview)

All Publications